Equities

Novanta Inc

Novanta Inc

Actions
TechnologyTechnology Hardware and Equipment
  • Price (USD)174.77
  • Today's Change0.97 / 0.56%
  • Shares traded137.70k
  • 1 Year change+15.90%
  • Beta1.3279
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Novanta Inc. is a supplier of core technology solutions, which give medical and advanced industrial original equipment manufacturers. The Company has three segments. Precision Medicine and Manufacturing segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, carbon dioxide laser, solid state laser, ultrafast laser, and optical light engine products to customers worldwide. Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless technologies, video recorders and video integration technologies, and others. Robotics and Automation segment designs, manufactures and markets optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide.

  • Revenue in USD (TTM)881.66m
  • Net income in USD72.88m
  • Incorporated--
  • Employees2.90k
  • Location
    Novanta Inc125 Middlesex TurnpikeBEDFORD 01730-1409United StatesUSA
  • Phone+1 (781) 266-5618
  • Fax+1 (781) 266-5114
  • Websitehttps://www.novanta.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
NOVT:NSQ since
announced
Transaction
value
Bearing Engineering IncDeal completed14 Nov 202314 Nov 2023Deal completed40.93%189.00m
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Enovis Corp1.71bn-54.37m3.41bn6.55k--0.997620.902.00-0.9987-0.611731.3362.610.38881.596.11260,640.80-1.23-0.3569-1.37-0.4158.2148.19-3.15-1.061.161.020.1199--9.22-4.89-40.29--11.91--
Axonics Inc366.38m-6.09m3.51bn797.00--5.49551.159.59-0.1285-0.12857.4312.560.53131.357.18459,697.60-0.8828-12.67-0.9601-13.7674.9470.04-1.66-29.688.98--0.00--33.86249.0689.80--23.65--
Envista Holdings Corp2.57bn-100.20m3.70bn12.80k--0.8855104.431.44-0.6022-0.602214.6524.340.38913.996.41200,507.80-1.521.94-1.792.3456.5257.65-3.905.291.905.120.26610.00-0.1012-2.04-142.10---4.22--
Integer Holdings Corp1.60bn90.65m3.84bn10.50k42.882.5220.282.412.682.6847.3045.580.55665.255.15152,064.103.163.283.433.5326.3026.945.686.401.713.540.38980.0016.035.6238.719.3321.71--
Lantheus Holdings Inc1.30bn326.66m4.14bn834.0013.035.0810.723.204.644.6418.5911.910.87239.465.211,554,471.0021.986.6925.757.7363.7153.9025.209.025.451,235.430.40810.0038.6530.441,063.8651.8135.48--
Haemonetics Corporation1.27bn126.57m4.27bn3.03k34.034.5319.413.362.472.4724.8018.570.62292.116.47418,649.006.214.747.055.8953.4849.779.977.411.7625.450.480.0017.675.27166.059.488.06--
Merit Medical Systems Inc1.26bn94.41m4.37bn6.95k46.643.6323.713.481.621.6221.5520.780.63042.367.34180,916.004.732.455.302.7746.4444.507.513.913.959.890.40640.009.247.3326.7015.86-11.16--
Glaukos Corp314.71m-134.66m4.59bn907.00--9.86--14.57-2.78-2.786.509.400.3241.898.29346,980.20-13.86-8.73-14.99-9.3575.9974.77-42.79-28.694.78-28.800.4335--11.2611.66-35.75--14.44--
Novanta Inc881.66m72.88m6.23bn2.90k85.929.2452.147.072.022.0224.4718.800.71473.046.36304,021.405.915.466.746.3445.3643.248.277.711.914.830.34770.002.417.49-1.588.214.19--
Inspire Medical Systems Inc624.80m-21.15m6.47bn1.01k--11.02--10.35-0.7298-0.729821.3219.371.014.228.27618,001.00-3.41-11.27-3.84-12.6084.5484.47-3.39-13.577.17--0.00--53.1965.3252.87--148.37--
DENTSPLY SIRONA Inc3.97bn-132.00m6.91bn15.00k--2.1032.741.74-0.6217-0.621718.6715.890.52823.005.98264,333.30-1.76-1.14-2.13-1.3252.7153.65-3.33-2.510.94673.630.3914--1.10-0.107186.11---4.549.86
Globus Medical Inc1.57bn122.87m7.18bn5.00k45.531.8126.754.581.171.1713.7229.320.4380.95574.38313,695.203.436.903.727.4565.0571.737.8314.052.72--0.09470.0053.3417.08-35.39-4.725.57--
MSA Safety Inc1.79bn58.52m7.60bn5.10k134.917.8963.674.251.431.4345.2124.590.78632.976.04350,518.802.585.083.036.0047.6745.213.287.021.486.070.383665.9117.005.65-67.41-13.664.72-1.10
Masimo Corp2.05bn81.50m7.64bn3.80k95.885.5942.543.731.511.5137.8425.850.65522.005.04538,973.702.618.653.2210.3149.0057.303.9812.031.223.430.3990.000.604219.00-43.21-15.9631.06--
Penumbra Inc1.06bn90.95m8.76bn4.20k97.717.4374.128.282.322.3227.0030.480.72321.045.23252,029.006.212.326.912.6164.4963.908.593.173.49--0.02150.0024.9518.934,643.1668.609.64--
Data as of Mar 28 2024. Currency figures normalised to Novanta Inc's reporting currency: US Dollar USD

Institutional shareholders

47.42%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20233.88m10.83%
The Vanguard Group, Inc.as of 31 Dec 20233.71m10.37%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 20231.89m5.27%
William Blair Investment Management LLCas of 31 Dec 20231.36m3.79%
Conestoga Capital Advisors LLCas of 31 Dec 20231.29m3.59%
SSgA Funds Management, Inc.as of 31 Dec 20231.22m3.40%
AllianceBernstein LPas of 31 Dec 2023951.62k2.66%
Neuberger Berman Investment Advisers LLCas of 31 Dec 2023933.53k2.61%
Wasatch Advisors, Inc.as of 31 Dec 2023921.54k2.57%
Macquarie Investment Management Business Trustas of 31 Dec 2023838.59k2.34%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.